Novel compounds target formation of amyloid peptides

08/4/2013 | Yahoo

A study published in Nature Communications has uncovered the mechanisms behind two types of compounds that could help fight Alzheimer's disease. Researchers are testing the two compounds to target gamma secretase, the enzyme that cuts longer proteins into components including the form of amyloid peptide that aggregates into toxic plaques. The latest research helps explain how the new compounds interact with gamma secretase.

View Full Article in:

Yahoo

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC